Aspen Aerogels, Inc. (NYSE:ASPN) Receives Consensus Recommendation of “Hold” from Analysts

Aspen Aerogels, Inc. (NYSE:ASPN) has been assigned an average recommendation of “Hold” from the six research firms that are covering the company, MarketBeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, one has issued a hold recommendation and three have assigned a buy recommendation to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $5.1875.

ASPN has been the subject of several research reports. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Aspen Aerogels in a report on Friday, March 27th. TD Cowen cut their price target on Aspen Aerogels from $7.00 to $6.00 and set a “buy” rating for the company in a report on Thursday, February 26th. Wall Street Zen raised Aspen Aerogels from a “sell” rating to a “hold” rating in a report on Saturday, May 16th. Roth Mkm reissued a “buy” rating and set a $5.75 target price on shares of Aspen Aerogels in a report on Friday, May 8th. Finally, Barclays lifted their target price on Aspen Aerogels from $3.00 to $4.00 and gave the stock an “underweight” rating in a report on Monday, May 11th.

Institutional Investors Weigh In On Aspen Aerogels

A number of hedge funds and other institutional investors have recently modified their holdings of ASPN. Invesco Ltd. increased its position in shares of Aspen Aerogels by 237.9% in the fourth quarter. Invesco Ltd. now owns 4,129,934 shares of the construction company’s stock worth $11,688,000 after purchasing an additional 2,907,558 shares during the period. Needham Investment Management LLC increased its position in shares of Aspen Aerogels by 26.5% in the fourth quarter. Needham Investment Management LLC now owns 4,351,700 shares of the construction company’s stock worth $12,315,000 after purchasing an additional 912,000 shares during the period. JPMorgan Chase & Co. increased its position in shares of Aspen Aerogels by 105.4% in the second quarter. JPMorgan Chase & Co. now owns 1,246,506 shares of the construction company’s stock worth $7,379,000 after purchasing an additional 639,753 shares during the period. Goldman Sachs Group Inc. increased its position in shares of Aspen Aerogels by 89.7% in the first quarter. Goldman Sachs Group Inc. now owns 1,274,356 shares of the construction company’s stock worth $8,143,000 after purchasing an additional 602,586 shares during the period. Finally, Peregrine Investment Management Inc. bought a new position in shares of Aspen Aerogels in the third quarter worth $4,176,000. Institutional investors and hedge funds own 97.64% of the company’s stock.

Aspen Aerogels Trading Down 5.2%

Shares of Aspen Aerogels stock opened at $5.90 on Thursday. The business has a fifty day simple moving average of $4.39 and a two-hundred day simple moving average of $3.67. Aspen Aerogels has a 1 year low of $2.30 and a 1 year high of $9.78. The company has a market capitalization of $488.58 million, a price-to-earnings ratio of -4.33 and a beta of 3.03. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.89 and a quick ratio of 2.54.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Thursday, May 7th. The construction company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.27) by ($0.01). Aspen Aerogels had a negative net margin of 48.64% and a negative return on equity of 22.16%. The business had revenue of $37.88 million for the quarter, compared to analyst estimates of $36.58 million. During the same period in the prior year, the business earned ($0.06) EPS. The company’s revenue for the quarter was down 51.8% compared to the same quarter last year. Aspen Aerogels has set its Q2 2026 guidance at -0.240–0.17 EPS. Research analysts forecast that Aspen Aerogels will post -0.8 EPS for the current year.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc, headquartered in Northborough, Massachusetts, develops and manufactures high-performance aerogel insulation materials and custom engineered solutions. Founded in 2001 as a spin-out from Department of Energy research, the company pursued an initial public offering on the NYSE in 2014 under the ticker ASPN. Aspen Aerogels combines proprietary aerogel formulations with advanced manufacturing processes to deliver products known for their low thermal conductivity, lightweight construction and robust mechanical properties.

The company’s product portfolio spans blanket insulation, boards, and custom shapes built around several proprietary brands, including Pyrogel, Cryogel and Spaceloft.